Home » Newsletters » BioWorld Asia

BioWorld Asia

May 10, 2000

View Archived Issues

Fluorescence Method Could Allow Rapid Screening For Cancer Drugs

Merger Between Vanguard, CeNeS Appears To Be Off

Computer Modeling Technology Aids Synergix In Drug Discovery

EU Implements New Rules Governing Orphan Drugs

PowderJect Presents 2 Studies Showing Validity Of Technology

Scotia Stock Falls Following Report Of Burns From Foscan

British Biotech Uses Expertise To Land Deal With ImmunoGen

Actelion Completes Phase III Study Of Hypertension Drug

Oxford GlycoSciences Publishes Results, Files For Protein Patents

Australia Academics Creating Two New Biotech Institutes

TVM Closes EUR300M Fund For Seed And Start-Up Firms

Tm Bioscience Boosts Genomics Reach Through Deal On Biochips

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.